Will metformin postpone high-fat diet promotion of TRAMP mouse prostate cancer development and progression?

International Urology and Nephrology

Volumn 46, Issue 12, 2014, Pages 2327-2334

  Xu, Hua ^a   Hu, Meng bo ^a   Bai, Pei de ^a   Zhu, Wen hui ^a   Ding, Qiang ^a   Jiang, Hao wen ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

High fat diet; Insulin like growth factor; Metformin; Prostate cancer; TRAMP

Indexed keywords

GLUCOSE; HEMATOXYLIN; INSULIN; METFORMIN; SOMATOMEDIN; GLUCOSE BLOOD LEVEL; SOMATOMEDIN C; TUMOR MARKER;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER TISSUE; CARCINOGENESIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL NEOPLASM; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; LIPID DIET; MALE; MOUSE; NONHUMAN; PROSTATE CANCER; STAINING; TEST MEAL; TRANSGENIC MOUSE; TUMOR PROMOTION; ADVERSE EFFECTS; ANALYSIS; ANIMAL; BLOOD; DISEASE COURSE; MORTALITY; PATHOLOGY; POLYMERASE CHAIN REACTION; PROSTATE TUMOR; RANDOMIZED CONTROLLED TRIAL;

ANIMALS; BLOOD GLUCOSE; DIET, HIGH-FAT; DISEASE PROGRESSION; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MALE; METFORMIN; MICE; MICE, TRANSGENIC; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84920989719     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-014-0823-x     Document Type: Article

References (29)

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10–29
2. Sim HG, Cheng CW (2005) Changing demography of prostate cancer in Asia. Eur J Cancer 41:834–845
3. Fleshner N, Bagnell PS, Klotz L, Venkateswaran V (2004) Dietary fat and prostate cancer. J Urol 171:S19–S24
4. Lophatananon A, Archer J, Easton D et al (2010) Dietary fat and early-onset prostate cancer risk. Br J Nutr 103:1375–1380
5. Kristal AR, Cohen JH, Qu P, Stanford JL (2002) Associations of energy, fat, calcium, and vitamin D with prostate cancer risk. Cancer Epidemiol Biomarkers Prev 11:719–725
6. Deneo-Pellegrini H, De Stefani E, Ronco A, Mendilaharsu M (1999) Foods, nutrients and prostate cancer: a case-control study in Uruguay. Br J Cancer 80:591–597
7. Andersson SO, Wolk A, Bergstrom R et al (1996) Energy, nutrient intake and prostate cancer risk: a population-based case-control study in Sweden. Int J Cancer 68:716–722
8. Pollard M, Luckert PH (1985) Promotional effects of testosterone and dietary fat on prostate carcinogenesis in genetically susceptible rats. Prostate 6:1–5
9. Pollard M, Luckert PH (1986) Promotional effects of testosterone and high fat diet on the development of autochthonous prostate cancer in rats. Cancer Lett 32:223–227
10. Tamano S, Rehm S, Waalkes MP, Ward JM (1996) High incidence and histogenesis of seminal vesicle adenocarcinoma and lower incidence of prostate carcinomas in the Lobund-Wistar prostate cancer rat model using N-nitrosomethylurea and testosterone. Vet Pathol 33:557–567
11. Carroll KK, Noble RL (1987) Dietary fat in relation to hormonal induction of mammary and prostatic carcinoma in Nb rats. Carcinogenesis 8:851–853
12. Pour PM, Groot K, Kazakoff K, Anderson K, Schally AV (1991) Effects of high-fat diet on the patterns of prostatic cancer induced in rats by N-nitrosobis(2-oxopropyl)amine and testosterone. Cancer Res 51:4757–4761
13. Panchal SK, Poudyal H, Iyer A et al (2011) High-carbohydrate high-fat diet-induced metabolic syndrome and cardiovascular remodeling in rats. J Cardiovasc Pharmacol 57:51–64
14. Gallou-Kabani C, Vige A, Gross MS et al (2007) C57BL/6 J and A/J mice fed a high-fat diet delineate components of metabolic syndrome. Obesity (Silver Spring) 15:1996–2005
15. Ben Sahra I, Laurent K, Loubat A et al (2008) The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level. Oncogene 27:3576–3586
16. Zhou G, Myers R, Li Y et al (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108:1167–1174
17. Bodmer WF (2000) Prostate cancer 2000. Prostate Cancer Prostatic Dis 3:218–223
18. Gingrich JR, Greenberg NM (1996) A transgenic mouse prostate cancer model. Toxicol Pathol 24:502–504
19. Gingrich JR, Barrios RJ, Morton RA et al (1996) Metastatic prostate cancer in a transgenic mouse. Cancer Res 56:4096–4102
20. Greenberg NM, DeMayo F, Finegold MJ et al (1995) Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 92:3439–3443
21. Park SH, Chang SN, Baek MW et al (2013) Effects of dietary high fat on prostate intraepithelial neoplasia in TRAMP mice. Lab Anim Res 29:39–47
22. Yki-Jarvinen H, K. Nikkila and S Makimattila (1999), Metformin prevents weight gain by reducing dietary intake during insulin therapy in patients with type 2 diabetes mellitus. Drugs 58(Suppl 1): 53–54; discussion 75–82
23. Wang Y, Corr JG, Thaler HT, Tao Y, Fair WR, Heston WD (1995) Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst 87:1456–1462
24. Saw CL, Wu TY, Paredes-Gonzalez X, Khor TO, Pung D, Kong AN (2011) Pharmacodynamics of fish oil: protective effects against prostate cancer in TRAMP mice fed with a high fat western diet. Asian Pac J Cancer Prev 12:3331–3334
25. Patel P, Abate N (2013) Body fat distribution and insulin resistance. Nutrients 5:2019–2027
26. Nasteska D, Harada N, Suzuki K, et al. (2014), Chronic reduction of GIP secretion alleviates obesity and insulin resistance under high fat diet condition. Diabetes 63:2332–2343
27. Kaklamani VG, Linos A, Kaklamani E, Markaki I, Koumantaki Y, Mantzoros CS (1999) Dietary fat and carbohydrates are independently associated with circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 concentrations in healthy adults. J Clin Oncol 17:3291–3298
28. Freedland SJ, Mavropoulos J, Wang A et al (2008) Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis. Prostate 68:11–19
29. Venkateswaran V, Haddad AQ, Fleshner NE et al (2007) Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts. J Natl Cancer Inst 99:1793–1800